HIV/AIDS Research
Pharma company submits three filings of antiretroviral agents to WHO
Published in AIDS Weekly, February 21st, 2005
Earlier this month, Ranbaxy had announced that it had begun filing data for its range of ARVs with the U.S. Food and Drug Administration (FDA) under it's expedited review process for the U.S. President's Emergency Program For Aids Relief (PEPFAR).
Speaking on the development, Dr. Brian W. Tempest, CEO and MD, Ranbaxy, said, "Ranbaxy fully supports WHO's prequalification project and we are working speedily to provide adequate fresh data to the WHO, on our generic...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2005-02-21)
More Articles from AIDS Weekly
- HAART Monitoring
HPLC/UV effective for therapeutic antiretroviral drug monitoring - HIV/AIDS Pathogenesis
Improved control of HIV-2 infection may relate to contribution of CD4 response - HIV/AIDS Research
Annexin II may be new target for prevention of HIV-1 infection - HIV/AIDS Therapy
Curcumin inhibits acetylation of HIV Tat by p300 as well as virus proliferation - HIV/AIDS Therapy
P-TEFb kinase inhibitor flavopiridol inhibits HIV transcription elongation - Alcohol Use
Many alcohol-dependent HIV patients need assistance adhering to medications - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
